Efficacy and safety of Ixazomib in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma: a real world, retrospective, non-interventional study
Latest Information Update: 22 Jul 2017
At a glance
- Drugs Ixazomib (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association